Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
Patients who were already enrolled in the ACA at the beginning of this year are also entitled to the increased financial aid.
During the COVID-19 pandemic, clinicians should be extremely mindful of assessing their own symptoms before making the decision about whether to treat patients or stay home.
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
The FDA has issued new guidance regarding the use of computerized behavioral therapy and other digital health therapeutic devices for psychiatric disorders during the coronavirus disease 2019 (COVID-19) pandemic.
To expedite development, the FDA has created a special emergency program called the Coronavirus Treatment Acceleration Program.
Cohort study data from 2018 to 2019 suggest poor compliance with the US Food and Drug Administration reporting requirements for clinical trial sponsors.
Many providers who are required to take recertification examinations feel as though standard CMS is just as effective in skill maintenance as studying and sitting for a 200-question examination.
A new study demonstrates the efficacy of a structured physician compensation model in achieving equitable pay for all employees, although the underrepresentation of women in leadership positions and the higher-paying specialties warrants further investigation.
